Impella heart pump study: safety and complications
Part of Heart & circulation clinical trials.
This study reviews how well people tolerated the Impella heart pump during cardiogenic shock and what complications occurred. It looks at past cases from 2010 to 2022 to help doctors understand the safety of this device.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were an adult (18 or older) when treated for cardiogenic shock.
- You were supported with an Impella 5, 5.5, or CP pump (not the 2.5 or RP versions).
- Your treatment with Impella happened between January 1, 2010, and December 31, 2022.
- The Impella could have been used alone or with other temporary heart support devices.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two support devices (Impella vs. IABP) for people with cardiogenic shock who are already on ECMO. It looks at how well the left side of the heart recovers when one of these devices is added.
This trial studies whether putting in a small heart pump early (through the leg) helps people with a heart attack complicated by severe heart weakness (“cardiogenic shock”) compared with standard treatment. It aims to improve survival and recovery by supporting blood flow sooner.
This study is for people in the intensive care unit who are using a heart pump called Impella. It will collect information about how well the heart pumps blood during treatment to help doctors learn more.
This trial is testing whether a temporary heart pump (Impella) can help people with severe heart failure and cardiogenic shock (when the heart can't pump enough blood). The goal is to see if this device can reduce fluid buildup and improve blood flow, but it's for people who are very ill and need extra support.
This study tests whether a special heart pump (Impella 5.5) can help patients with severe heart failure (cardiogenic shock) safely start and increase their heart failure medications. The goal is to see if this approach can help the heart recover and improve outcomes.
This study looks at when to insert a small heart pump (Impella CP) in people who have had a heart attack and are in cardiogenic shock, a condition where the heart can't pump enough blood. The goal is to find out if placing the pump before or after the artery-opening procedure improves outcomes.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.